223 related articles for article (PubMed ID: 26990621)
41. [Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
Derkach KV; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Kuznetsova VS; Shpakov AO
Biomed Khim; 2022 Dec; 68(6):427-436. PubMed ID: 36573409
[TBL] [Abstract][Full Text] [Related]
42. Discovery of Bisindole as a Novel Scaffold for Protein Tyrosine Phosphatase 1B Inhibitors.
Jing C; Li Z; Jia K; Chen C; Liu X; Wang B; Hu W; Li J; Zhu T; Dong S
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28029177
[TBL] [Abstract][Full Text] [Related]
43. Fucosterol activates the insulin signaling pathway in insulin resistant HepG2 cells via inhibiting PTP1B.
Jung HA; Bhakta HK; Min BS; Choi JS
Arch Pharm Res; 2016 Oct; 39(10):1454-1464. PubMed ID: 27544192
[TBL] [Abstract][Full Text] [Related]
44. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
45. Essential role of protein-tyrosine phosphatase 1B in the modulation of insulin signaling by acetaminophen in hepatocytes.
Mobasher MA; de Toro-Martín J; González-Rodríguez Á; Ramos S; Letzig LG; James LP; Muntané J; Álvarez C; Valverde ÁM
J Biol Chem; 2014 Oct; 289(42):29406-19. PubMed ID: 25204659
[TBL] [Abstract][Full Text] [Related]
46. 3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics: hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitor.
Tang YB; Liu JZ; Zhang SE; Du X; Nie F; Tian JY; Ye F; Huang K; Hu JP; Li Y; Xiao Z
ChemMedChem; 2014 May; 9(5):918-21. PubMed ID: 24644278
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors.
Tang YB; Lu D; Chen Z; Hu C; Yang Y; Tian JY; Ye F; Wu L; Zhang ZY; Xiao Z
Bioorg Med Chem Lett; 2013 Apr; 23(8):2313-8. PubMed ID: 23499238
[TBL] [Abstract][Full Text] [Related]
48. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
[TBL] [Abstract][Full Text] [Related]
49. A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.
Yang Z; Wu F; He Y; Zhang Q; Zhang Y; Zhou G; Yang H; Zhou P
Food Funct; 2018 Jan; 9(1):397-406. PubMed ID: 29215104
[TBL] [Abstract][Full Text] [Related]
50. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.
Delibegovic M; Zimmer D; Kauffman C; Rak K; Hong EG; Cho YR; Kim JK; Kahn BB; Neel BG; Bence KK
Diabetes; 2009 Mar; 58(3):590-9. PubMed ID: 19074988
[TBL] [Abstract][Full Text] [Related]
51. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
[TBL] [Abstract][Full Text] [Related]
52. PTP1B inhibitors from Selaginella tamariscina (Beauv.) Spring and their kinetic properties and molecular docking simulation.
Le DD; Nguyen DH; Zhao BT; Seong SH; Choi JS; Kim SK; Kim JA; Min BS; Woo MH
Bioorg Chem; 2017 Jun; 72():273-281. PubMed ID: 28499188
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
54. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
[TBL] [Abstract][Full Text] [Related]
55. Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation.
Bettaieb A; Bakke J; Nagata N; Matsuo K; Xi Y; Liu S; AbouBechara D; Melhem R; Stanhope K; Cummings B; Graham J; Bremer A; Zhang S; Lyssiotis CA; Zhang ZY; Cantley LC; Havel PJ; Haj FG
J Biol Chem; 2013 Jun; 288(24):17360-71. PubMed ID: 23640882
[TBL] [Abstract][Full Text] [Related]
56. [CD36 gene deletion reduces muscle insulin sensitivity in mice by up-regulating PTP1B expression].
Chen L; Zeng H; Qin H; Ruan X; Yang P
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):392-398. PubMed ID: 35426803
[TBL] [Abstract][Full Text] [Related]
57. Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in Obesity.
Brown AP; Saravanan C; Devine P; Magnifico M; Gao J; Beaulieu V; Ma F; Yasoshima K; Barnes-Seeman D; Yamada K
Int J Toxicol; 2017; 36(4):303-313. PubMed ID: 28592157
[TBL] [Abstract][Full Text] [Related]
58. Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
Liu P; Du Y; Song L; Shen J; Li Q
Bioorg Med Chem; 2015 Nov; 23(21):7079-88. PubMed ID: 26481657
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, biological evaluation, and molecular docking study of some new rohitukine analogs as protein tyrosine phosphatase 1B inhibitors.
Balaramnavar VM; Srivastava R; Varshney S; Kumar S; Rawat AK; Chandasana H; Chhonker YS; Bhatta RS; Srivastava AK; Gaikwad AN; Lakshmi V; Saxena AK
Bioorg Chem; 2021 May; 110():104829. PubMed ID: 33773222
[TBL] [Abstract][Full Text] [Related]
60. Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.
Owen C; Lees EK; Grant L; Zimmer DJ; Mody N; Bence KK; Delibegović M
Diabetologia; 2013 Oct; 56(10):2286-96. PubMed ID: 23832083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
